Clinical Trial Update: Effectiveness and Safety of Campath in Combination With Tacrolimus Monotherapy to Prevent Kidney Graft Rejection [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the effectiveness and safety of alemtuzumab (Campath) in combination with tacrolimus monotherapy to prevent kidney graft rejec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• CAMPATH (ALEMTUZUMAB)
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Dr. Claudia Bösmüller | Conditions: Kidney Transplantation | Phase 3 | Status: COMPLETED